A detailed history of Dark Forest Capital Management LP transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 19,649 shares of EDIT stock, worth $54,427. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,649
Holding current value
$54,427
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.39 - $5.96 $66,610 - $117,108
19,649 New
19,649 $67,000
Q3 2023

Nov 13, 2023

BUY
$6.92 - $9.31 $241,646 - $325,105
34,920 New
34,920 $272,000
Q1 2022

May 13, 2022

SELL
$14.08 - $27.63 $5,111 - $10,029
-363 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$26.55 - $40.57 $9,478 - $14,483
357 Added 5950.0%
363 $10,000
Q3 2021

Nov 12, 2021

BUY
$39.27 - $72.94 $235 - $437
6 New
6 $0

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $190M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.